SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

ARS Pharmaceuticals, Inc. (SPRY) News

Track canonical SquawkNews coverage tagged to SPRY, ARS Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 13 indexed stories across 7 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol SPRY Asset equity Sector Markets 90 days 13 Last 4.12 Updated Sep 15, 2026, 01:27 PM UTC Open live news feed
L SPRY - LAWSUIT ALERT: Investors Who Lost Over $100,000 With ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) Shares - Purchased Between March and June 2026 - Should Contact the Shareholders Foundation SPRY - LAWSUIT ALERT: Investors Who Lost Over $100,000 With ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) Shares - Purchased Between March and June 2026 - Should Contact the Shareholders Foundation REGULATION | Sep 15, 2026, 01:27 PM UTC L ARS Pharmaceuticals CEO to participate in upcoming investor conferences ARS Pharmaceuticals said Donn Casale, President and CEO, will participate in upcoming investor conferences, according to a company announcement. EQUITY | Sep 01, 2026, 08:08 PM UTC L SPRY - ARS Pharmaceuticals to Participate in Upcoming Investor Conferences SPRY - ARS Pharmaceuticals to Participate in Upcoming Investor Conferences EQUITY | Sep 01, 2026, 08:01 PM UTC L ARS Pharmaceuticals outlines priorities and reports Q2 2026 results ARS Pharmaceuticals outlines strategic priorities, including a focused commercial strategy, and reports its second quarter 2026 financial results. EARNINGS | Aug 13, 2026, 08:02 PM UTC L SPRY - ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Secon SPRY - ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results EARNINGS | Aug 03, 2026, 11:30 AM UTC M Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday U.S. stocks were slightly lower, with the Dow Jones index falling around 0.1% on Friday. Shares of Apogee Enterprises In c (NASDAQ: APOG ) rose sharply after the company reported better-than-expected first-quarter financ EARNINGS | Jun 26, 2026, 01:39 PM UTC M ARS Pharma Reaffirms 2027 Breakeven Goal ARS Pharmaceuticals reaffirms its expectation to achieve cash-flow breakeven in 2027 despite missing July Neffy coverage wins EARNINGS | Jun 25, 2026, 05:34 PM UTC M 12 Health Care Stocks Move Multiple health care stocks are moving in Thursday's intraday session, with gainers including Atlantic International and SELLAS Life Sciences, and losers including Nano X Imaging and Passage Bio EQUITY | Jun 25, 2026, 05:05 PM UTC H SPRY -24% on Update SPRY falls 24% premarket after providing commercial and financial updates, while other big cap stocks also decline on various news EQUITY | Jun 25, 2026, 12:17 PM UTC M FUL, TCOM, HTZ Drop H.B. Fuller, Trip.com, and Hertz Global are among the stocks moving lower in Thursday's pre-market session EQUITY | Jun 25, 2026, 12:08 PM UTC M SPRY Lowers Guidance ARS Pharmaceuticals lowers FY26 cash operating expense guidance, shares trade lower EARNINGS | Jun 24, 2026, 08:48 PM UTC M ARS Pharma Lowers 2026 Expense Guidance ARS Pharma lowers 2026 cash operating expense guidance to $248M and reaffirms path to cash-flow breakeven in 2027 EARNINGS | Jun 24, 2026, 08:44 PM UTC